Pathogenesis and Novel Targeted Therapies of Psoriasis
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 1713
Special Issue Editor
Interests: psoriasis; biologic treatment; microbiome; alopecia; hair loss; systemic sclerosis; lupus; atopic dermatitis; immunosupressants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Psoriasis is a chronic and recurrent immune-mediated skin disease with a prevalence of approximately 2–3% worldwide. According to current knowledge, psoriasis is a systemic, multifactorial disease that develops in genetically predisposed individuals under various environmental factors. Recently, a large number of studies have highlighted the role of gut and skin microbiota in the onset and progression of psoriasis.
Despite undisputed achievements in basic and clinical sciences over the last few decades, we still do not fully understand this disease. The complexity of psoriasis is also affected by the several comorbidities, including metabolic syndrome, cardiovascular diseases, psoriatic arthritis or depression.
This Special Issue is now open to contributions, and aims to explore the latest updates of all aspects of psoriasis including its pathogenesis, biomarkers, comorbidities and therapy.
We look forward to receiving your best original and review papers.
Dr. Mariusz Sikora
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psoriasis
- psoriatic arthritis
- genetics
- immunology
- therapy
- biologics
- biomarkers
- microbiota
- comorbidities
- skin
- IL-23/IL-17 axis